首頁 › 卵巢癌 › 印第安納 › Fort Wayne
Fort Wayne, IN 的 卵巢癌 臨床試驗
8 項針對 卵巢癌 的研究正在 Fort Wayne（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Parkview Research Center /ID# 274338, Fort Wayne
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center ( Site 0055), Fort Wayne
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中2 期
- Parkview Research Center, Fort Wayne
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center ( Site 0003), Fort Wayne
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Parkview Regional Medical Center, Fort Wayne
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Integrated Cancer Repository for Cancer Research
招募中觀察性研究歡迎健康志工
- Parkview Research Center, Fort Wayne
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Fort Wayne 的其他研究
- 非小細胞肺癌17 項研究
- 癌症（所有類型）7 項研究
- 慢性淋巴性白血病7 項研究
- 乳癌7 項研究
- 肺癌6 項研究
- 轉移性癌症6 項研究
- 子宮內膜癌5 項研究
- 黑色素瘤4 項研究
- 頭頸部鱗狀細胞癌4 項研究
- 三陰性乳癌4 項研究
- 大腸直腸癌4 項研究
- 多發性骨髓瘤4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。